Advances into Understanding the Vital Role of the Mitochondrial Citrate Carrier (CIC) in Metabolic Diseases
- 1 November 2020
- journal article
- review article
- Published by Elsevier in Pharmacological Research
- Vol. 161, 105132
Abstract
No abstract availableKeywords
Funding Information
- ational Natural Science Foundation of China (81472735);)
- Wuhan University (Jing Liu, (2042019kf0206); N)
- ational Basic Research Program of China (2015CB932600))
This publication has 63 references indexed in Scilit:
- Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viabilityProceedings of the National Academy of Sciences, 2011
- Imaging Cycling Tumor HypoxiaCancer Research, 2010
- AT-1 is the ER membrane acetyl-CoA transporter and is essential for cell viabilityJournal of Cell Science, 2010
- Inhibitors of the Mitochondrial Citrate Transport Protein: Validation of the Role of Substrate Binding Residues and Discovery of the First Purely Competitive InhibitorMolecular Pharmacology, 2010
- A conserved role for the mitochondrial citrate transporter Sea/SLC25A1 in the maintenance of chromosome integrityHuman Molecular Genetics, 2009
- ATP-Citrate Lyase Links Cellular Metabolism to Histone AcetylationScience, 2009
- Chromatin Challenges during DNA Replication and RepairCell, 2007
- Highly conserved charge-pair networks in the mitochondrial carrier familyJournal of Molecular Biology, 1998
- Branch-point reactions in the biosynthesis of cholesterol, dolichol, ubiquinone and prenylated proteinsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- Structure, function and regulation of the tricarboxylate transport protein from rat liver mitochondriaJournal of Bioenergetics and Biomembranes, 1993